Razmpoosh Elham, Safi Sara, Nadjarzadeh Azadeh, Salehi-Abargouei Amin, Mazaheri Mahta, Mirmiran Parvin, Meyre David
Nutrition and Endocrine Research Center, Research Institute for Endocrine Sciences, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Department of Nutrition, School of Public Health, Shahid Sadoughi University of Medical Sciences, Yazd, Iran.
Br J Nutr. 2022 May 11:1-10. doi: 10.1017/S0007114522001428.
Adipocyte expansion through adipogenesis can offset the adverse metabolic effects of obesity. (NS) (black seed) oil is shown to have therapeutic features in the management of obesity. NS oil might have beneficial changes in obese populations through mediating serum levels of adipogenesis-related parameters and relative transcriptional gene-diet interactions (nutrigenomics), though no previous studies assessed this mechanism in overweight/obese participants. This study assessed the effects of NS oil supplements on blood concentration and mRNA expression levels of TNF-, PPAR- and serum adiponectin and expression of , as major adipogenesis and obesity-related parameters, in overweight/obese women using a cross-over design. Eligible women were randomised to receive either NS oil supplements (2000 mg/d) or placebo. Two periods of interventions (8 weeks in each) were cross-changed by a 4-week washout period. An individualised diet plan without calorie deficits was given to participants to match their energy/macronutrient intakes. The Pkcross procedure and intention-to-treat analysis were performed using Stata. was estimated to measure the magnitude of the effects. Forty-six participants were included. NS oil capsules reduced transcription levels (( = -2·31), < 0·001) and blood concentrations of TNF- (( = -0·29), < 0·001). AdipoR1 expression ( = 2·24, < 0·001) and serum adiponectin ( = 0·88, < 0·001) showed a significant augmentation with a medium-high effect size, as did gene expression ( = 0·69, < 0·001) and serum levels of PPAR- ( = 0·97, < 0·001). There was a moderate but significant decrease in body weight ( = 0·6, < 0·001). The present beneficial findings would provide strong information for future nutrigenomics/clinical trial studies assessing the role of NS in the management of obesity and other comorbidities.
通过脂肪生成实现的脂肪细胞扩张可以抵消肥胖的不良代谢影响。黑种草籽油在肥胖管理方面具有治疗特性。黑种草籽油可能通过调节脂肪生成相关参数的血清水平以及相对转录基因 - 饮食相互作用(营养基因组学),在肥胖人群中产生有益变化,尽管此前尚无研究在超重/肥胖参与者中评估此机制。本研究采用交叉设计,评估了黑种草籽油补充剂对超重/肥胖女性血液中肿瘤坏死因子 -α(TNF-α)、过氧化物酶体增殖物激活受体 -γ(PPAR-γ)浓度和mRNA表达水平以及脂联素血清水平和脂联素受体1(AdipoR1)表达的影响,这些是主要的脂肪生成和肥胖相关参数。符合条件的女性被随机分为接受黑种草籽油补充剂(2000毫克/天)或安慰剂组。两个为期8周的干预期通过4周的洗脱期交叉进行。为参与者提供了无热量赤字的个性化饮食计划,以匹配他们的能量/宏量营养素摄入量。使用Stata进行交叉分析程序和意向性分析。估计效应大小以衡量效果的大小。纳入了46名参与者。黑种草籽油胶囊降低了TNF-α的转录水平(β = -2.31,P < 0.001)和血液浓度(β = -0.29,P < 0.001)。AdipoR1表达(β = 2.24,P < 0.001)和血清脂联素(β = 0.88,P < 0.001)显示出显著增加,效应大小为中高,PPAR-γ的基因表达(β = 0.69,P < 0.001)和血清水平(β = 0.97,P < 0.001)也是如此。体重有适度但显著的下降(β = 0.6,P < 0.001)。目前的有益发现将为未来评估黑种草在肥胖及其他合并症管理中作用的营养基因组学/临床试验研究提供有力信息。